Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases
Notice of a collaboration agreement with Renascience, Inc. to develop antisense oligonucleotides for treating hereditary neurological intractable diseases
Luxna Biotech Co. Ltd. and Renascience, Inc. have signed a collaboration agreement to develop antisense oligonucleotides to treat hereditary neurological intractable diseases.
